UA102462U - METHOD OF OBTAINING A STABILIZED SOLUTION - Google Patents

METHOD OF OBTAINING A STABILIZED SOLUTION

Info

Publication number
UA102462U
UA102462U UAU201505326U UAU201505326U UA102462U UA 102462 U UA102462 U UA 102462U UA U201505326 U UAU201505326 U UA U201505326U UA U201505326 U UAU201505326 U UA U201505326U UA 102462 U UA102462 U UA 102462U
Authority
UA
Ukraine
Prior art keywords
water
stabilizer
pharmaceutically acceptable
acceptable salt
obtaining
Prior art date
Application number
UAU201505326U
Other languages
Russian (ru)
Ukrainian (uk)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to UAU201505326U priority Critical patent/UA102462U/en
Publication of UA102462U publication Critical patent/UA102462U/en

Links

Abstract

Спосіб одержання стабілізованого розчину полягає у тому, що у воді розчиняють одну із активних речовин та стабілізатор і потім в утвореному розчині при перемішуванні розчиняють другу активну речовину до її повного розчинення. Як активні речовини використовують гіалуронову кислоту та/або її фармацевтично прийнятну сіль та декаметоксин та/або його розчинну у воді сіль, а стабілізатор є фармацевтично прийнятною сіллю, що здатна до розчинення у воді і дисоціації у водних розчинах на катіони металів та аніони кислотних залишків, або сумішшю таких солей. При цьому стабілізатор має здатність утворювати одночасно з гіалуроновою кислотою та/або її фармацевтично прийнятною сіллю та з декаметоксином та/або його розчинною у воді сіллю розчинні у воді сполуки.The method of obtaining a stable solution is that one of the active substances and the stabilizer is dissolved in water and then the second active substance is dissolved in the formed solution with stirring until it is completely dissolved. Hyaluronic acid and / or its pharmaceutically acceptable salt and decamethoxine and / or its water-soluble salt are used as the active substances, and the stabilizer is a pharmaceutically acceptable salt capable of dissolving in water and dissociating in aqueous solutions to metal cations and anions of acid residues, or a mixture of such salts. In this case, the stabilizer has the ability to form concurrently with hyaluronic acid and / or its pharmaceutically acceptable salt and with decamethoxin and / or its water-soluble salt.

UAU201505326U 2015-05-29 2015-05-29 METHOD OF OBTAINING A STABILIZED SOLUTION UA102462U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201505326U UA102462U (en) 2015-05-29 2015-05-29 METHOD OF OBTAINING A STABILIZED SOLUTION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201505326U UA102462U (en) 2015-05-29 2015-05-29 METHOD OF OBTAINING A STABILIZED SOLUTION

Publications (1)

Publication Number Publication Date
UA102462U true UA102462U (en) 2015-10-26

Family

ID=54773946

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201505326U UA102462U (en) 2015-05-29 2015-05-29 METHOD OF OBTAINING A STABILIZED SOLUTION

Country Status (1)

Country Link
UA (1) UA102462U (en)

Similar Documents

Publication Publication Date Title
NI201700128A (en) OBETICOLIC ACID COMPOSITIONS AND METHODS OF USE.
MX2018001006A (en) Pharmaceutical composition comprising an adenoviral vector.
EA201000438A1 (en) METHOD FOR OBTAINING PRODUCTS OF CELLULOSE HYDROLYSIS SOLUBLE IN WATER
MY190283A (en) Method for producing crystals of diazabicyclooctane derivative and stable lyophilized preparation
MY176359A (en) Electrode for electrochlorination processes and method of manufacturing thereof
MX2016011290A (en) Lipoic acid choline ester compositions and methods of use.
BR112017026796B8 (en) AQUEOUS COMPOSITIONS FOR PRODUCING CHLORINE DIOXIDE BY CONTACT WITH AN ACID, METHOD FOR PRODUCING CHLORINE DIOXIDE AND CLEANING IN PLACE SYSTEM
MY169131A (en) Aqueous solutions containing a complexing agent in high concentration
EA201691825A1 (en) STABILIZED SOLUTION ON THE BASIS OF ACTIVE SUBSTANCES, METHOD FOR OBTAINING A STABILIZED SOLUTION OF ACTIVE SUBSTANCES, PHARMACEUTICAL COMPOSITION ON THE BASIS OF A STABILIZED SOLUTION OF ACTIVE SUBSTANCES (TWO OPTIONS)
MX2018007112A (en) Fast dissolving peroxymonosulfate composition.
EA201691066A1 (en) SOLUTIONS TO IMPROVE STABILITY AND LIFE OF SOLUTION FOR CONSERVING BODIES AND FABRICS
CL2017001091A1 (en) Method of crystallization of α-lactose from an aqueous solution
MX2015012211A (en) Ionic liquids and uses thereof.
UA102462U (en) METHOD OF OBTAINING A STABILIZED SOLUTION
PH12018502693A1 (en) Crystal of amino acid salt of 3-hydroxyisovaleric acid and production method thereof
MY186384A (en) Mixed salts of hydroxyalkane sulfinic acid
UA102463U (en) STABILIZED SOLUTION
UA102461U (en) PHARMACEUTICAL COMPOSITION
UA102464U (en) PHARMACEUTICAL COMPOSITION
UA116892C2 (en) PHARMACEUTICAL COMPOSITION
RU2014108338A (en) DISINFECTANT COMPOSITION
PL423551A1 (en) Method for obtaining the suspension containing nanoparticles of melatonin
PH12018501046B1 (en) Crystal of monovalent cation salt of 3-hydroxyisovaleric acid and process for producing the crystals
EA201391512A1 (en) SOLID PHARMACEUTICAL COMPOSITION
UA94392U (en) Stabilized solution based on decametoxine